These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36632070)

  • 1. 3D printed matrix solid forms: Can the drug solubility and dose customisation affect their controlled release behaviour?
    Dos Santos J; Balbinot GS; Buchner S; Collares FM; Windbergs M; Deon M; Beck RCR
    Int J Pharm X; 2023 Dec; 5():100153. PubMed ID: 36632070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple variable effects in the customisation of fused deposition modelling 3D-printed medicines: A design of experiments (DoE) approach.
    Dos Santos J; Deon M; da Silva GS; Beck RCR
    Int J Pharm; 2021 Mar; 597():120331. PubMed ID: 33540012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D printing of pharmaceutical oral solid dosage forms by fused deposition: The enhancement of printability using plasticised HPMCAS.
    Oladeji S; Mohylyuk V; Jones DS; Andrews GP
    Int J Pharm; 2022 Mar; 616():121553. PubMed ID: 35131354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of immediate release (IR) 3D-printed oral dosage forms with focus on industrial relevance.
    Fanous M; Gold S; Hirsch S; Ogorka J; Imanidis G
    Eur J Pharm Sci; 2020 Dec; 155():105558. PubMed ID: 32946957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D-Printed Isoniazid Tablets for the Treatment and Prevention of Tuberculosis-Personalized Dosing and Drug Release.
    Öblom H; Zhang J; Pimparade M; Speer I; Preis M; Repka M; Sandler N
    AAPS PharmSciTech; 2019 Jan; 20(2):52. PubMed ID: 30617660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabrication of an osmotic 3D printed solid dosage form for controlled release of active pharmaceutical ingredients.
    Gioumouxouzis CI; Tzimtzimis E; Katsamenis OL; Dourou A; Markopoulou C; Bouropoulos N; Tzetzis D; Fatouros DG
    Eur J Pharm Sci; 2020 Feb; 143():105176. PubMed ID: 31809907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fused deposition modeling 3D printing of solid oral dosage forms containing amorphous solid dispersions: How to elucidate drug dissolution mechanisms through surface spectral analysis techniques?
    Parulski C; Gresse E; Jennotte O; Felten A; Ziemons E; Lechanteur A; Evrard B
    Int J Pharm; 2022 Oct; 626():122157. PubMed ID: 36055443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of modified release 3D printed tablets (printlets) with pharmaceutical excipients using additive manufacturing.
    Goyanes A; Fina F; Martorana A; Sedough D; Gaisford S; Basit AW
    Int J Pharm; 2017 Jul; 527(1-2):21-30. PubMed ID: 28502898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eudragit
    Dos Santos J; da Silva GS; Velho MC; Beck RCR
    Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(ɛ-caprolactone) and Eudragit E blends modulate the drug release profiles from FDM printlets.
    Dos Santos J; Kielholz T; Funk NL; Balbinot GS; Daitx TDS; Petzhold CL; Buchner S; Collares FM; Windbergs M; Beck RCR
    Int J Pharm; 2023 Nov; 647():123533. PubMed ID: 37863446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hot-Melt 3D Extrusion for the Fabrication of Customizable Modified-Release Solid Dosage Forms.
    Lee J; Song C; Noh I; Song S; Rhee YS
    Pharmaceutics; 2020 Aug; 12(8):. PubMed ID: 32764499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D Printing of Tunable Zero-Order Release Printlets.
    Fina F; Goyanes A; Rowland M; Gaisford S; W Basit A
    Polymers (Basel); 2020 Aug; 12(8):. PubMed ID: 32784645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production.
    Fanous M; Gold S; Muller S; Hirsch S; Ogorka J; Imanidis G
    Int J Pharm; 2020 Mar; 578():119124. PubMed ID: 32035253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of porosity on drug release kinetics of swellable and erodible porous pharmaceutical solid dosage forms fabricated by hot melt droplet deposition 3D printing.
    Zhang B; Nasereddin J; McDonagh T; von Zeppelin D; Gleadall A; Alqahtani F; Bibb R; Belton P; Qi S
    Int J Pharm; 2021 Jul; 604():120626. PubMed ID: 33957266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets.
    Shi K; Salvage JP; Maniruzzaman M; Nokhodchi A
    Int J Pharm; 2021 Mar; 597():120315. PubMed ID: 33540000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immediate release 3D printed oral dosage forms: How different polymers have been explored to reach suitable drug release behaviour.
    Funk NL; Fantaus S; Beck RCR
    Int J Pharm; 2022 Sep; 625():122066. PubMed ID: 35926751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Veering to a Continuous Platform of Fused Deposition Modeling Based 3D Printing for Pharmaceutical Dosage Forms: Understanding the Effect of Layer Orientation on Formulation Performance.
    Kulkarni VR; Chakka J; Alkadi F; Maniruzzaman M
    Pharmaceutics; 2023 Apr; 15(5):. PubMed ID: 37242565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of immediate release 3D-printed dosage forms for a poorly water-soluble drug by fused deposition modeling: Study of morphology, solid state and dissolution.
    Fanous M; Bitar M; Gold S; Sobczuk A; Hirsch S; Ogorka J; Imanidis G
    Int J Pharm; 2021 Apr; 599():120417. PubMed ID: 33647418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can filaments, pellets and powder be used as feedstock to produce highly drug-loaded ethylene-vinyl acetate 3D printed tablets using extrusion-based additive manufacturing?
    Samaro A; Shaqour B; Goudarzi NM; Ghijs M; Cardon L; Boone MN; Verleije B; Beyers K; Vanhoorne V; Cos P; Vervaet C
    Int J Pharm; 2021 Sep; 607():120922. PubMed ID: 34303815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Effective Technology for the Development of Immediate Release Solid Dosage Forms Containing Low-Dose Drug: Fused Deposition Modeling 3D Printing.
    Gültekin HE; Tort S; Acartürk F
    Pharm Res; 2019 Jun; 36(9):128. PubMed ID: 31250313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.